STAC3 and neoplasm: Notably, ASP/NAM-mediated m6A reduction occurred in additional tumor cell lines following ASP/NAM treatment (Supplementary Fig. 4c), which correlated with enhanced METTL3 acetylation (Supplementary Fig. 4d).